<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC526469/" ref="ordinalpos=3853&amp;ncbi_uid=389141&amp;link_uid=PMC526469" image-link="/pmc/articles/PMC526469/figure/f6/" class="imagepopup">Figure 6.  From: Small proline-rich protein 1A is a gp130 <span class="highlight" style="background-color:">pathway</span>- and stress-inducible cardioprotective protein. </a></div><br /><div class="p4l_captionBody">Working model for SPRR1A activation in the myocardium. In response to myocardial injuries, IL-6 cytokines are released and act on the surrounding cells (left panel). The binding of IL-6 cytokines (CT-1, LIF) to gp130/LIFR receptor complex activates STAT3, PI-3K, and MAPK signaling pathways (right panel). A MAPK signaling pathway activates the transcription factors C/EBPÎ² and AP-1. In turn, they bind to SPRR1A promoter and induce SPRR1A gene transcription. SPRR1A confers a protective effect to the cardiomyocytes, possibly by stabilizing the actin cytoskeleton.</div></div>